Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Glioblastoma × selinexor × Clear all

Phase

Status

Terminated 2 Suspended 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Bevacizumab 2 selinexor 1 pembrolizumab 1 Temozolomide 1 TPI-287 1 Surgical Procedures, Operative 1 Radiosurgery 1 Niacinamide 1 Niacin 1 Metformin 1 Diet, Ketogenic 1 Craniotomy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05432804 2026-03-18

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

National Cancer Institute (NCI)

Phase 1/2 Suspended

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡